Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
13%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
IDNA
44
HOLDINGS
32%
ALSO IN BBP
BBP
65
HOLDINGS
20%
ALSO IN IDNA
SECTOR DRIFT (IDNA minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
INCYTE CORP | 4.7% | 2.0% | 2.0% |
|
BIOCRYST PHARMACEUTICALS INC | 2.3% | 1.8% | 1.8% |
|
EXELIXIS INC | 3.2% | 1.8% | 1.8% |
 |
BIONTECH SE SPONSORED ADR | 3.5% | 1.5% | 1.5% |
|
NOVAVAX INC | 2.5% | 1.4% | 1.4% |
IDNA Overweight Relative to BBP
 |
GENMAB A/S | 4.8% |
|
REVOLUTION MEDICINES, INC. | 4.7% |
|
ARCELLX, INC. | 4.4% |
|
CELCUITY INC. | 4.4% |
 |
ASTRAZENECA PLC | 4.1% |
|
MERCK & CO. INC. | 3.9% |
|
TWIST BIOSCIENCE CORP. | 3.8% |
|
GSK PLC | 3.8% |
 |
ROCHE HOLDING LTD | 3.7% |
 |
SANOFI-AVENTIS | 3.7% |
IDNA Underweight Relative to BBP
|
INSMED INC | -3.3% |
|
BRIDGEBIO PHARMA, INC. | -3.2% |
|
ALNYLAM PHARMACEUTICALS INC | -3.0% |
|
RHYTHM PHARMACEUTICALS, INC. | -3.0% |
|
MIRUM PHARMACEUTICALS, INC. | -3.0% |
|
BEIGENE LTD. SPONSORED ADR | -2.9% |
|
IONIS PHARMACEUTICALS, INC. | -2.7% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
ASCENDIS PHARMA A/S | -2.6% |
|
HALOZYME THERAPEUTICS INC | -2.6% |